Emergent Biosolutions reported $24M in Pre-Tax Profit for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Acadia Pharmaceuticals ACAD:US $ -14.79M 28.61M
Akebia Therapeutics AKBA:US $ -59.54M 23.49M
Alnylam Pharmaceuticals ALNY:US $ -212.93M 24.6M
Amarin AMRN:US $ -12.97M 21.83M
Chimerix CMRX:US $ -18.56M 0.8M
Coherus Biosciences CHRS:US $ -38.53M 11.22M
Exact Sciences EXAS:US $ -170.8M 2.09M
Exelixis EXEL:US $ 53.26M 71.63M
Flexion Therapeutics FLXN:US $ -30312000 8.1M
Immunogen IMGN:US $ -37.34M 6.6M
Intercept Pharmaceuticals ICPT:US $ -3.63M 7.46M
IONIS PHARMACEUT IONS:US $ -84M 3M
Lonza Group LONN:SW 496.49M 151.49M
Moderna Inc MRNA:US 3.55B 489M
Nektar Therapeutics NKTR:US $ -129.59M 4.43M
Neurocrine Biosciences NBIX:US $ 30.5M 27M
Opko Health OPK:US $ 31.47M 31.74M
Ptc Therapeutics PTCT:US $ -133.66M 15.78M
Sarepta Therapeutics SRPT:US $ -47.91M 33.85M
Teva Pharmaceutical Industries TEVA:US $ 807M 13M
United Therapeutics UTHR:US $ 204.4M 12.1M
Vanda Pharmaceuticals VNDA:US $ 10.72M 1.88M
Xoma XOMA:US $ -4.44M 2.2M